These compounds have demonstrated cardioprotective effects against myocardial infarction and I/R injury by modulating signaling pathways such as the PI3K/Akt, ​Akt/Erk1/2/Nrf2, and ​JAK2/STAT3 pathways 36. This evidence concerns the gene AKT1 and myocardial infarction.